VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 124 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,737,190 | +363.8% | 439,191 | +669.2% | 0.02% | +400.0% |
| Q1 2023 | $1,452,624 | -80.9% | 57,100 | -78.0% | 0.00% | -84.6% |
| Q4 2022 | $7,597,258 | +29.2% | 260,091 | -9.3% | 0.03% | +13.0% |
| Q3 2022 | $5,880,000 | -35.7% | 286,707 | -63.7% | 0.02% | -41.0% |
| Q2 2022 | $9,145,000 | +64.9% | 790,400 | +163.5% | 0.04% | +77.3% |
| Q1 2022 | $5,547,000 | -40.7% | 300,000 | -36.6% | 0.02% | -40.5% |
| Q4 2021 | $9,349,000 | -6.8% | 472,864 | -22.5% | 0.04% | -15.9% |
| Q3 2021 | $10,035,000 | +38.7% | 610,000 | +54.2% | 0.04% | +33.3% |
| Q2 2021 | $7,234,000 | +9.5% | 395,534 | 0.0% | 0.03% | +6.5% |
| Q1 2021 | $6,609,000 | – | 395,534 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |